Dechra Pharmaceuticals PLC Holding(s) in Company (0217D)
21 April 2017 - 11:03PM
UK Regulatory
TIDMDPH
RNS Number : 0217D
Dechra Pharmaceuticals PLC
21 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or DECHRA PHARMACEUTICALS
the underlying issuer PLC
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ ------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
------------------------------------------------------- -----------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------- -----------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------- -----------------------
An event changing the breakdown of voting rights
------------------------------------------------------- -----------------------
Other (please
specify):
----------------------------------------------------- -----------------------
3. Full name of person(s) FMR LLC
subject to the
notification obligation:
(iii)
------------------------------------------------------ ------------------------
4. Full name of shareholder(s) See Section 9
(if different from 3.):(iv)
------------------------------------------------------ ------------------------
5. Date of the transaction 19 April 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ ------------------------
6. Date on which issuer 21 April 2017
notified:
------------------------------------------------------ ------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 10%
------------------------------------------------------ ------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- ----------------------- -------------------------
Indirect Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- --------- ------------ ------------ -----------
GB0009633180 9,309,883 9,309,883 9,315,883 9,315,883 10.00%
---------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
---------------- -------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
9,315,883 10.00%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------------------------
Controlled Undertaking Percentage Holding
FIAM LLC 0.11
FIDELITY MANAGEMENT & RESEARCH (JAPAN)
LIMITED 0.05
FMR CO., INC 8.82
FMR INVESTMENT MANAGEMENT (UK) LIMITED 1.02
Grand Total 10.00
---------------------------------------- -------------------
------------------------------------------------------------------------------------------------
Proxy Voting:
------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------------ ----------------------------
11. Number of voting rights proxy
holder will acquire/ cease to hold:
------------------------------------------------------------------ ----------------------------
12. Date on which proxy holder will
acquire/ cease to hold voting rights:
------------------------------------------------------------------ ----------------------------
13. Additional information: N/A
---------------------------------------------------------------- ------------------------------
14. Contact name: Sally-Ann Hatton
---------------------------------------------------------------- ------------------------------
15. Contact telephone number:
fil-regreporting@fil.com,
01737 837148
---------------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGMGZDFMMGNZM
(END) Dow Jones Newswires
April 21, 2017 09:03 ET (13:03 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2023 to Apr 2024
